Page 112

Category Archives: Cardiomyopathies

Cytokinetics Announces New Results Presented at the International Symposium on ALS/MNDSubgroup Analyses of FORTITUDE-ALS on Effects of Reldesemtiv…

Posted: December 8, 2019 at 7:47 pm

SOUTH SAN FRANCISCO, Calif., Dec. 05, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Inc.(Nasdaq: CYTK) today announced that new results were presented at the 30th International Symposium on ALS/MND in Perth, Australia, including additional analyses from FORTITUDE-ALS (Functional Outcomes in a Randomized Trial of Investigational Treatment with CK-2127107 to Understand Decline in Endpoints in ALS), the Phase 2 clinical trial of reldesemtiv in patients with amyotrophic lateral sclerosis (ALS). Among the post-hoc analyses presented were results of subgroup analyses describing the effect of reldesemtiv with and without use of Radicava (edaravone) and/or Rilutek (riluzole) and the interaction between quality of life and depression in the placebo group. Continue reading

Posted in Cardiomyopathies | Comments Off on Cytokinetics Announces New Results Presented at the International Symposium on ALS/MNDSubgroup Analyses of FORTITUDE-ALS on Effects of Reldesemtiv…

Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies – Pharmaceutical…

Posted: November 29, 2019 at 8:46 pm

Lonza and DiNAQOR AG, a global gene therapy platform company, announced a strategic collaboration to advance DiNAQOR's preclinical programs for the treatment of cardiac myosin-binding protein-C (MYBPC3) cardiomyopathies, a genetic condition that can result in heart failure. Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies. Continue reading

Posted in Cardiomyopathies | Comments Off on Lonza and DiNAQOR announce strategic collaboration to advance gene therapy programs for patients with monogenic cardiomyopathies – Pharmaceutical…

Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies – PRNewswire

Posted: at 8:46 pm

BASEL,Switzerland and PFFFIKON,Switzerland, Nov. Continue reading

Posted in Cardiomyopathies | Comments Off on Lonza and DiNAQOR AG Announce Strategic Collaboration to Advance Gene Therapy Programs for Patients with Monogenic Cardiomyopathies – PRNewswire

Cytokinetics to Announce Third Quarter Results on October 31, 2019 – Yahoo Finance

Posted: October 24, 2019 at 7:48 pm

SOUTH SAN FRANCISCO, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced that it is scheduled to report third quarter results on October 31, 2019 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics senior management will host a conference call at 4:30 PM Eastern Time to discuss operational and financial results and the companys outlook for the future Continue reading

Posted in Cardiomyopathies | Comments Off on Cytokinetics to Announce Third Quarter Results on October 31, 2019 – Yahoo Finance

Cell Culture Protein Surface Coating Market Current Outlook Of Industry & Forecast 2017 2025 – Health News Office

Posted: at 7:48 pm

Global Cell Culture Protein Surface Coating Market: Snapshot The global market for cell culture protein surface coatings is slated to expand at a highly promising pace in the next few years, thanks to the vast rise in investments by governments and market players in stem cell research and development activities. Cell culturing is a method used for growing artificial living cells outside the natural environment, under controlled physical conditions Continue reading

Posted in Cardiomyopathies | Comments Off on Cell Culture Protein Surface Coating Market Current Outlook Of Industry & Forecast 2017 2025 – Health News Office

Cardiac Surgery Instruments Market to be Fueled by Increasing Threat of Cardiovascular Diseases – Online News Guru

Posted: October 21, 2019 at 6:41 pm

The TMR report projects the globalcardiac surgery instruments marketto register an impressive CAGR of 5.9% from 2017 to 2022. Continue reading

Posted in Cardiomyopathies | Comments Off on Cardiac Surgery Instruments Market to be Fueled by Increasing Threat of Cardiovascular Diseases – Online News Guru

Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting – Yahoo Finance

Posted: October 9, 2019 at 1:43 am

Faster Progressing Patients Who Received Reldesemtiv in the TrialDemonstrated Statistically Significant Differences in the Decline in ALSFRS-R Total Score SOUTH SAN FRANCISCO, Calif., Oct. 04, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (CYTK) today announced additional analyses of FORTITUDE-ALS (Functional Outcomes in a Randomized Trial of Investigational Treatment with CK-2127107 to Understand Decline in Endpoints in ALS), the Phase 2 clinical trial ofreldesemtivin patients with amyotrophic lateral sclerosis (ALS). Continue reading

Posted in Cardiomyopathies | Comments Off on Cytokinetics Announces Presentation of Additional Analyses From FORTITUDE-ALS at the 18th Annual NEALS Meeting – Yahoo Finance

Cardiovascular Genomic Diagnostics Market Estimated to Expand at a Robust CAGR over 2018 2028 – Space Market Research

Posted: at 1:43 am

Heart related disorders are mostly inherited from parents to their children. Cardiovascular genomic diagnostics testing helps in detecting these inherited diseases such as cardiac channelopathies and congenital heart diseases. Besides cardiovascular genomic diagnostics can also be helpful for family members who have risks of developing heart problems Continue reading

Posted in Cardiomyopathies | Comments Off on Cardiovascular Genomic Diagnostics Market Estimated to Expand at a Robust CAGR over 2018 2028 – Space Market Research

Cardiovascular Genomic Diagnostics Market to Record an Exponential CAGR by 2025 – Rapid News Network

Posted: September 22, 2019 at 12:52 am

Heart related disorders are mostly inherited from parents to their children. Cardiovascular genomic diagnostics testing helps in detecting these inherited diseases such as cardiac channelopathies and congenital heart diseases. Continue reading

Posted in Cardiomyopathies | Comments Off on Cardiovascular Genomic Diagnostics Market to Record an Exponential CAGR by 2025 – Rapid News Network

Cardiac Surgery Instruments Market Prospects and Growth Assessment – TodayTimes

Posted: at 12:52 am

The rising prevalence of cardiac disorders all over the world has boosted the Cardiac Surgery Instruments Market in present day. Cardiac surgery instruments market is also drawing benefits from cross-channel demand in order to improve medical care and services Continue reading

Posted in Cardiomyopathies | Comments Off on Cardiac Surgery Instruments Market Prospects and Growth Assessment – TodayTimes

Page 112